Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

NCT04220684

Conditions: Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Bone Marrow Diseases, +10 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

IL-13 Blockade and Airway Autoimmunity in Asthma

NCT05564078

Conditions: Airway Auto Immunity in Asthma, Asthma, Bronchial Diseases, +13 more
Locations: The Research Institute of St. Joe's Hamilton Hamilton, Ontario, Canada

View Trial Details

Completed

Severe PID With Lymphoproliferation and Neutropenia

NCT03427593

Conditions: Agranulocytosis, Autoimmune Diseases, Common Variable Immunodeficiency, +12 more
Locations: Service d'Immunologie Clinique et VIH - Hôpital Civil Strasbourg, France

View Trial Details

Completed

Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment

NCT06715943

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Hematology Hospital of Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Identification of New Markers in the Hypereosinophilic Syndrome

NCT01713504

Conditions: Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: CHRU, Hôpital Claude Huriez Lille, Nord, France

View Trial Details

Completed

Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT02619682

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

NCT03042689

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Massachusetts general Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach

NCT05387564

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Nemours Children's Hospital, Delware Wilmington, Delaware, United States

View Trial Details

Completed

Hydroxyurea and EPO in Sickle Cell Disease

NCT05451940

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: UPMC Pittsburgh, Pennsylvania, United States

Lagos University Teaching Hospital Lagos, Nigeria

View Trial Details

Completed

Optimizing Dosing Strategies in Oral Iron Supplementation

NCT06238895

Conditions: Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +8 more
Locations: Luzerner Kantonsspital Lucerne, Switzerland

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions